INAB
IN8BIO, INC.
Company overview
- Market capitalization
- $12.22M
- Employees
- 18
- Latest publication
- 2026-09-29
About IN8BIO, INC.
IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its lead product candidates include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company also develops INB-619, a gamma-delta TCE targeting CD19 for both oncology and autoimmune diseases; INB-300, a nsCAR-enabled DeltEx product candidates targeting difficult liquid tumors and extracranial solid tumors; INB-500, an induced pluripotent stem cell derived gamma-delta T cells that are in preclinical phase for treatment of cancer; and INB-600, a gamma-Delta T cell engager. In addition, it is developing INB-619, a gamma-delta TCE targeting CD19 for potential applications in both oncology and autoimmune diseases. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 2,526,000USD | 0USD | 0USD |
| Cost Of Revenue | 500,000USD | 1,173,000USD | — | 498,000USD | 429,000USD | 1,263,000USD | 690,000USD | 631,000USD |
| Gross Profit | -500,000USD | -1,173,000USD | — | -498,000USD | -429,000USD | -702,000USD | -690,000USD | -631,000USD |
| Research Development | 2,613,000USD | 2,648,000USD | 2,104,000USD | 2,487,000USD | 2,972,000USD | 3,594,000USD | 3,309,000USD | 5,156,000USD |
| Selling General Administrative | 2,653,000USD | 2,385,000USD | 1,863,000USD | 2,714,000USD | 2,688,000USD | 2,630,000USD | 2,732,000USD | 3,533,000USD |
| Total Operating Expenses | 4,766,000USD | 4,942,000USD | 3,854,000USD | 5,094,000USD | 5,550,000USD | 6,160,000USD | 7,086,000USD | 8,629,000USD |
| Operating Income | -5,266,000USD | -4,942,000USD | -3,854,000USD | -5,094,000USD | -5,550,000USD | -6,160,000USD | -7,086,000USD | -8,629,000USD |
| Interest Income | 176,000USD | 91,000USD | 113,000USD | 107,000USD | 110,000USD | 64,000USD | 23,000USD | 60,000USD |
| Net Interest Income | 176,000USD | 91,000USD | 113,000USD | 107,000USD | 110,000USD | 64,000USD | 23,000USD | 60,000USD |
| Income Before Tax | -5,090,000USD | -4,942,000USD | -3,854,000USD | -5,094,000USD | -5,550,000USD | -6,160,000USD | -7,086,000USD | -8,629,000USD |
| Net Income | -5,090,000USD | -4,942,000USD | -3,854,000USD | -5,094,000USD | -5,550,000USD | -6,160,000USD | -7,086,000USD | -8,629,000USD |
| Net Income From Continuing Ops | -5,090,000USD | -4,942,000USD | -3,854,000USD | -5,094,000USD | -5,550,000USD | -6,160,000USD | -7,086,000USD | -8,629,000USD |
| Ebit | -5,090,000USD | -5,033,000USD | -3,854,000USD | -5,201,000USD | -5,660,000USD | -6,224,000USD | -6,041,000USD | -8,689,000USD |
| Ebitda | -4,590,000USD | -4,512,000USD | -3,327,000USD | -4,417,000USD | -4,991,000USD | -5,522,000USD | -5,351,000USD | -8,058,000USD |
| Depreciation And Amortization | 500,000USD | 521,000USD | 527,000USD | 784,000USD | 669,000USD | 702,000USD | 690,000USD | 631,000USD |
| Reconciled Depreciation | 500,000USD | 521,000USD | 527,000USD | 784,000USD | 669,000USD | 702,000USD | 690,000USD | 631,000USD |
| Total Other Income Expense Net | 176,000USD | 91,000USD | — | 107,000USD | 110,000USD | 64,000USD | -1,068,000USD | 60,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | 1,045,000USD | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 631,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 2,501,000USD | 2,655,000USD | 1,103,000USD | 251,000USD | 96,000USD | 96,000USD | 96,000USD |
| Gross Profit | -2,501,000USD | -2,655,000USD | -1,103,000USD | -251,000USD | -96,000USD | -96,000USD | -96,000USD |
| Research Development | 10,211,000USD | 16,962,000USD | 14,062,000USD | 7,347,000USD | 5,378,000USD | 2,358,000USD | 581,000USD |
| Selling General Administrative | 9,650,000USD | 12,637,000USD | 14,459,000USD | 7,306,000USD | 3,179,000USD | 2,708,000USD | 1,423,000USD |
| Unclassified Operating Expenses | -2,501,000USD | — | — | — | — | — | — |
| Total Operating Expenses | 17,360,000USD | 30,437,000USD | 28,521,000USD | 14,653,000USD | 8,557,000USD | 5,066,000USD | 2,004,000USD |
| Operating Income | -19,861,000USD | -30,437,000USD | -28,521,000USD | -14,653,000USD | -8,557,000USD | -5,134,000USD | -2,004,000USD |
| Interest Income | 421,000USD | 230,000USD | — | — | — | — | — |
| Net Interest Income | 421,000USD | 230,000USD | — | — | — | 0USD | -14,000USD |
| Income Before Tax | -19,440,000USD | -30,437,000USD | -28,521,000USD | -14,653,000USD | -8,557,000USD | -5,134,000USD | -2,081,000USD |
| Net Income | -19,440,000USD | -30,437,000USD | -27,418,000USD | -14,653,000USD | -8,557,000USD | -5,134,000USD | -2,081,000USD |
| Net Income From Continuing Ops | -19,440,000USD | -30,437,000USD | -28,521,000USD | -14,653,000USD | -8,557,000USD | -5,134,000USD | -2,081,000USD |
| Ebit | -19,440,000USD | -29,599,000USD | -28,521,000USD | -14,653,000USD | -8,557,000USD | -5,134,000USD | -2,067,000USD |
| Ebitda | -16,939,000USD | -26,944,000USD | -27,418,000USD | -13,865,000USD | -8,469,000USD | -5,038,000USD | -1,971,000USD |
| Depreciation And Amortization | 2,501,000USD | 2,655,000USD | 1,103,000USD | 788,000USD | 88,000USD | 96,000USD | 96,000USD |
| Reconciled Depreciation | 2,501,000USD | 2,655,000USD | 1,103,000USD | 788,000USD | 88,000USD | 96,000USD | 96,000USD |
| Total Other Income Expense Net | 421,000USD | -838,000USD | — | — | — | -68,000USD | -77,000USD |
| Interest Expense | — | — | 1,103,000USD | 788,000USD | 0USD | 0USD | 14,000USD |
| Income Tax Expense | — | — | -1,103,000USD | 551,442USD | -118,297USD | -68,000USD | -63,000USD |
| Net Income Applicable To Common Shares | — | — | — | -14,653,000USD | -10,340,000USD | -5,912,000USD | -2,509,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 26,265,000USD | 32,282,000USD | 16,768,000USD | 19,371,000USD | 19,869,000USD | 20,944,000USD | 15,966,000USD | 22,496,000USD |
| Other Current Assets | 721,000USD | 788,000USD | 1,079,000USD | 515,000USD | 837,000USD | 1,458,000USD | 2,702,000USD | 2,465,000USD |
| Total Liab | 3,484,000USD | 4,724,000USD | 3,579,000USD | 4,132,000USD | 5,992,000USD | 6,466,000USD | 7,378,000USD | 8,875,000USD |
| Total Stockholder Equity | 22,781,000USD | 27,558,000USD | 13,189,000USD | 15,239,000USD | 13,877,000USD | 14,478,000USD | 8,588,000USD | 13,621,000USD |
| Other Current Liab | 681,000USD | 1,633,000USD | 418,000USD | 635,000USD | 1,145,000USD | 1,047,000USD | 769,000USD | 1,533,000USD |
| Common Stock | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 8,000USD | 7,000USD | 5,000USD | 5,000USD |
| Capital Stock | 10,000USD | 10,000USD | 10,000USD | 10,000USD | 8,000USD | 7,000USD | 5,000USD | 5,000USD |
| Retained Earnings | -146,186,000USD | -141,096,000USD | -136,154,000USD | -132,300,000USD | -127,206,000USD | -121,656,000USD | -115,496,000USD | -108,410,000USD |
| Cash | 21,941,000USD | 27,092,000USD | 10,689,000USD | 13,226,000USD | 11,888,000USD | 11,120,000USD | 4,001,000USD | 10,217,000USD |
| Cash And Short Term Investments | 21,941,000USD | 27,092,000USD | 10,689,000USD | 13,226,000USD | 11,888,000USD | 11,120,000USD | 4,001,000USD | 10,217,000USD |
| Total Current Assets | 22,662,000USD | 27,880,000USD | 11,768,000USD | 13,741,000USD | 12,725,000USD | 12,578,000USD | 6,703,000USD | 12,682,000USD |
| Total Current Liabilities | 2,158,000USD | 3,161,000USD | 1,703,000USD | 1,954,000USD | 2,957,000USD | 3,083,000USD | 3,635,000USD | 4,759,000USD |
| Net Debt | -19,587,000USD | -24,310,000USD | -7,732,000USD | -10,108,000USD | -7,616,000USD | -6,090,000USD | 1,471,000USD | -4,319,000USD |
| Short Term Debt | 1,028,000USD | 1,219,000USD | 1,081,000USD | 940,000USD | 1,237,000USD | 1,647,000USD | 1,729,000USD | 1,782,000USD |
| Short Long Term Debt Total | 2,354,000USD | 2,782,000USD | 2,957,000USD | 3,118,000USD | 4,272,000USD | 5,030,000USD | 5,472,000USD | 5,898,000USD |
| Accounts Payable | 449,000USD | 309,000USD | 204,000USD | 379,000USD | 575,000USD | 389,000USD | 1,137,000USD | 1,444,000USD |
| Property Plant Equipment Net | 3,254,000USD | 4,036,000USD | 4,558,000USD | 5,084,000USD | 6,600,000USD | 7,825,000USD | 8,499,000USD | 9,235,000USD |
| Property Plant Equipment Gross | 6,698,000USD | 7,235,000USD | 7,512,000USD | 7,858,000USD | 9,119,000USD | 10,088,000USD | 10,507,000USD | 10,991,000USD |
| Common Stock Shares Outstanding | 4,374,328shares | 4,374,328shares | 4,537,683shares | 4,119,153shares | 83,482,125shares | 56,673,563shares | 47,321,394shares | 45,126,064shares |
| Non Current Assets Total | 3,603,000USD | 4,402,000USD | 5,000,000USD | 5,630,000USD | 7,144,000USD | 8,366,000USD | 9,263,000USD | 9,814,000USD |
| Non Current Liabilities Total | 1,326,000USD | 1,563,000USD | 1,876,000USD | 2,178,000USD | 3,035,000USD | 3,383,000USD | 3,743,000USD | 4,116,000USD |
| Non Currrent Assets Other | 349,000USD | 146,000USD | 169,000USD | 275,000USD | 275,000USD | 275,000USD | 505,000USD | 320,000USD |
| Net Working Capital | 20,504,000USD | 24,719,000USD | 10,065,000USD | 11,787,000USD | 9,768,000USD | 9,495,000USD | 3,068,000USD | 7,923,000USD |
| Unclassified Non Current Liabilities | 1,326,000USD | 1,563,000USD | 1,876,000USD | 2,178,000USD | 3,035,000USD | 3,383,000USD | 3,743,000USD | 4,116,000USD |
| Unclassified Equity | 168,947,000USD | 168,634,000USD | 149,323,000USD | 147,519,000USD | 141,067,000USD | 136,120,000USD | 124,074,000USD | 122,021,000USD |
| Other Assets | — | — | — | — | — | -1,043,000USD | — | 1USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 32,282,000USD | 20,944,000USD | 33,709,000USD | 33,039,000USD | 42,223,000USD | 20,910,000USD | 1,130,000USD | 5,895,000USD |
| Other Current Assets | 788,000USD | 1,458,000USD | 3,343,000USD | 4,052,000USD | 1,959,000USD | 150,000USD | 153,000USD | 52,000USD |
| Total Liab | 4,724,000USD | 6,466,000USD | 8,772,000USD | 10,307,000USD | 4,040,000USD | 2,589,000USD | 1,476,000USD | 1,248,000USD |
| Total Stockholder Equity | 27,558,000USD | 14,478,000USD | 24,937,000USD | 22,732,000USD | 38,183,000USD | 18,321,000USD | -346,000USD | 4,647,000USD |
| Other Current Liab | 1,633,000USD | 1,047,000USD | 2,955,000USD | 2,342,000USD | 1,235,000USD | 1,778,000USD | 87,000USD | — |
| Common Stock | 10,000USD | 7,000USD | 4,000USD | 3,000USD | 2,000USD | 1,000USD | 1,000USD | 1,000USD |
| Capital Stock | 10,000USD | 7,000USD | 4,000USD | 3,000USD | 2,000USD | 34,901,000USD | 8,897,000USD | 8,897,000USD |
| Retained Earnings | -141,096,000USD | -121,656,000USD | -91,219,000USD | -61,212,000USD | -32,691,000USD | -18,038,000USD | -9,481,000USD | -4,347,000USD |
| Cash | 27,092,000USD | 11,120,000USD | 21,282,000USD | 18,182,000USD | 37,021,000USD | 17,994,000USD | 610,000USD | 4,990,000USD |
| Cash And Short Term Investments | 27,092,000USD | 11,120,000USD | 21,282,000USD | 18,182,000USD | 37,021,000USD | 17,994,000USD | 610,000USD | 4,990,000USD |
| Total Current Assets | 27,880,000USD | 12,578,000USD | 24,625,000USD | 22,234,000USD | 38,980,000USD | 18,144,000USD | 763,000USD | 5,072,000USD |
| Total Current Liabilities | 3,161,000USD | 3,083,000USD | 5,393,000USD | 5,822,000USD | 2,256,000USD | 2,572,000USD | 647,000USD | 419,000USD |
| Net Debt | -24,310,000USD | -6,090,000USD | -16,389,000USD | -12,308,000USD | -34,611,000USD | -17,820,000USD | -610,000USD | -4,990,000USD |
| Short Term Debt | 1,219,000USD | 1,647,000USD | 1,514,000USD | 1,389,000USD | 626,000USD | 174,000USD | — | — |
| Short Long Term Debt Total | 2,782,000USD | 5,030,000USD | 4,893,000USD | 5,874,000USD | 2,410,000USD | 174,000USD | — | — |
| Accounts Payable | 309,000USD | 389,000USD | 924,000USD | 2,091,000USD | 395,000USD | 620,000USD | 560,000USD | 419,000USD |
| Property Plant Equipment Net | 4,036,000USD | 7,825,000USD | 8,573,000USD | 10,298,000USD | 2,834,000USD | 186,000USD | 274,000USD | 795,000USD |
| Property Plant Equipment Gross | 7,235,000USD | 10,088,000USD | 9,856,000USD | 10,298,000USD | 3,180,000USD | 186,000USD | 274,000USD | 795,000USD |
| Common Stock Shares Outstanding | 4,374,328shares | 53,547,030shares | 29,865,000shares | 20,968,000shares | 18,781,242shares | 19,354,553shares | 19,354,553shares | 19,354,553shares |
| Non Current Assets Total | 4,402,000USD | 8,366,000USD | 9,084,000USD | 10,805,000USD | 3,243,000USD | 2,766,000USD | 367,000USD | 823,000USD |
| Non Current Liabilities Total | 1,563,000USD | 3,383,000USD | 3,379,000USD | 4,485,000USD | 1,784,000USD | 17,000USD | 829,000USD | 829,000USD |
| Non Currrent Assets Other | 146,000USD | 275,000USD | 255,000USD | 381,000USD | 409,000USD | 2,580,000USD | 93,000USD | 28,000USD |
| Net Working Capital | 24,719,000USD | 9,495,000USD | 19,232,000USD | 16,412,000USD | 36,724,000USD | 15,572,000USD | 116,000USD | 4,653,000USD |
| Unclassified Non Current Liabilities | 1,563,000USD | 3,383,000USD | 3,379,000USD | 4,485,000USD | 1,784,000USD | -2,439,000USD | — | — |
| Unclassified Equity | 168,634,000USD | 136,120,000USD | 116,148,000USD | 83,938,000USD | 113,093,000USD | 1,714,000USD | — | — |
| Intangible Assets | — | — | — | 126,000USD | — | — | — | — |
| Other Assets | — | — | — | — | 409,000USD | 2,580,000USD | 93,000USD | 28,000USD |
| Accumulated Other Comprehensive Income | — | — | — | — | -42,223,000USD | -257,000USD | -169,000USD | -133,000USD |
| Net Tangible Assets | — | — | — | — | 38,183,000USD | -16,579,000USD | -9,242,000USD | -4,249,000USD |
| Deferred Long Term Liab | — | — | — | — | — | 2,439,000USD | — | — |
| Other Liab | — | — | — | — | — | 17,000USD | — | — |
| Short Long Term Debt | — | — | — | — | — | 174,000USD | — | — |
| Unclassified Non Current Assets | — | — | — | — | — | -2,580,000USD | — | — |
| Net Receivables | — | — | — | — | — | — | — | 30,000USD |
| Inventory | — | — | — | — | — | — | — | 15,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -5,090,000USD | -4,942,000USD | -3,854,000USD | -5,094,000USD | -5,550,000USD | -6,160,000USD | -7,086,000USD | -8,629,000USD |
| Depreciation | 353,000USD | 537,000USD | 401,000USD | 541,000USD | 669,000USD | 702,000USD | 690,000USD | 631,000USD |
| Stock Based Compensation | 401,000USD | 711,000USD | 692,000USD | 955,000USD | 831,000USD | 825,000USD | 1,764,000USD | 1,171USD |
| Other Non Cash Items | 147,000USD | -16,000USD | 818,000USD | 243,000USD | — | 825,000USD | 45,000USD | 1,169,829USD |
| Change In Working Capital | -758,000USD | 1,571,000USD | -889,000USD | -572,000USD | 928,000USD | 605,000USD | -1,524,000USD | 736,000USD |
| Total Cash From Operating Activities | -4,947,000USD | -2,139,000USD | -3,524,000USD | -3,927,000USD | -3,122,000USD | -4,027,999USD | -6,111,000USD | -6,091,000USD |
| Capital Expenditures | -9,000USD | 0USD | 0USD | 0USD | -33,000USD | -33,000USD | -83,000USD | -83,000USD |
| Free Cash Flow | -4,956,000USD | -2,139,000USD | -3,524,000USD | -3,927,000USD | -3,122,000USD | -4,061,000USD | -6,111,000USD | -6,174,000USD |
| Total Cashflows From Investing Activities | -9,000USD | — | — | — | -33,000USD | -33,000USD | 83,000USD | -83,000USD |
| Net Borrowings | -107,000USD | -111,000USD | -123,000USD | -234,000USD | -225,000USD | -219,000USD | -213,000USD | — |
| Total Cash From Financing Activities | -195,000USD | 18,489,000USD | 989,000USD | 5,267,000USD | 3,893,000USD | 11,187,000USD | -105,000USD | 3,379,000USD |
| Issuance Of Capital Stock | 0USD | 25,183,000USD | -5,468,000USD | 3,617,000USD | 3,735,000USD | 6,126,000USD | 289,000USD | 3,528,000USD |
| Change In Cash | -5,151,000USD | 16,350,000USD | -2,537,000USD | 1,340,000USD | 771,000USD | 7,119,000USD | -6,216,000USD | -2,798,000USD |
| Begin Period Cash Flow | 27,312,000USD | 10,962,000USD | 13,226,000USD | 12,157,000USD | 11,386,000USD | 4,001,000USD | 10,217,000USD | 13,015,000USD |
| End Period Cash Flow | 22,161,000USD | 27,312,000USD | 10,689,000USD | 13,497,000USD | 12,157,000USD | 11,120,000USD | 4,001,000USD | 10,217,000USD |
| Other Cashflows From Financing Activities | -195,000USD | 18,489,000USD | 989,000USD | — | 383,000USD | 5,280,000USD | -181,000USD | 25,000USD |
| Unclassified Financing Cash Flow | — | -25,072,000USD | 5,591,000USD | 1,884,000USD | — | — | 8,588,250,000USD | -8,584,607,000USD |
| Investments | — | — | 0USD | 0USD | 0USD | -33,000USD | 0USD | -83,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | -8,587,961,000USD | 8,587,961,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -19,440,000USD | -30,437,000USD | -30,007,000USD | -14,653,000USD | -8,557,000USD | -5,134,000USD | -2,081,000USD |
| Depreciation | 1,771,000USD | 2,655,000USD | 2,501,000USD | 788,000USD | 88,000USD | 96,000USD | 96,000USD |
| Stock Based Compensation | 3,189,000USD | 5,000,000USD | 4,370,000USD | 2,195,000USD | 357,000USD | 76,000USD | 31,000USD |
| Other Non Cash Items | 730,000USD | 45,000USD | 4,370,000USD | 541,000USD | 368,000USD | 68,000USD | 70,000USD |
| Change In Working Capital | 1,038,000USD | -1,412,000USD | -204,000USD | -1,839,000USD | 611,000USD | 93,000USD | -885,000USD |
| Total Cash From Operating Activities | -12,712,000USD | -24,149,000USD | -23,340,000USD | -13,509,000USD | -7,133,000USD | -4,801,000USD | -2,769,000USD |
| Capital Expenditures | 0USD | -104,000USD | -600,000USD | -309,000USD | -309,000USD | -330,000USD | -757,000USD |
| Free Cash Flow | -12,712,000USD | -24,253,000USD | -23,940,000USD | -13,818,000USD | -7,133,000USD | -5,131,000USD | -3,526,000USD |
| Net Borrowings | -693,000USD | -794,000USD | -798,000USD | -709,000USD | 174,000USD | 174,000USD | 1,264,000USD |
| Total Cash From Financing Activities | 28,638,000USD | 14,184,000USD | 27,044,000USD | 32,955,000USD | 24,517,000USD | 65,000USD | 8,501,000USD |
| Issuance Of Capital Stock | 27,067,000USD | 9,943,000USD | 24,564,000USD | 36,327,000USD | 25,674,000USD | 0USD | 7,237,000USD |
| Change In Cash | 15,926,000USD | -10,152,000USD | 3,100,000USD | 19,137,000USD | 17,384,000USD | -4,380,000USD | 4,975,000USD |
| Begin Period Cash Flow | 11,386,000USD | 21,538,000USD | 18,182,000USD | 18,135,000USD | 610,000USD | 4,990,000USD | 15,000USD |
| End Period Cash Flow | 27,312,000USD | 11,386,000USD | 21,282,000USD | 37,272,000USD | 17,994,000USD | 610,000USD | 4,990,000USD |
| Other Cashflows From Financing Activities | 28,638,000USD | 5,035,000USD | 3,278,000USD | -2,663,000USD | 23,844,000USD | 65,000USD | 14,474,000USD |
| Unclassified Financing Cash Flow | -26,374,000USD | — | — | — | -25,175,000USD | — | -14,474,000USD |
| Investments | — | -187,000USD | -600,000USD | -309,000USD | 0USD | 356,000USD | -757,000USD |
| Total Cashflows From Investing Activities | — | -187,000USD | -600,000USD | -309,000USD | -309,000USD | 356,000USD | -757,000USD |
| Other Cashflows From Investing Activities | — | -83,000USD | — | -309,000USD | — | 686USD | — |
| Unclassified Operating Cash Flow | — | — | -4,370,000USD | — | — | — | — |
| Change To Liabilities | — | — | — | -319,000USD | -160,000USD | 141,000USD | -152,000USD |
| Change To Account Receivables | — | — | — | — | — | 30,000USD | -30,000USD |
| Change To Inventory | — | — | — | — | — | -30,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.